What is One Nucleus? Vision. Mission
|
|
- Lewis Newman
- 6 years ago
- Views:
Transcription
1 One Nucleus
2 What is One Nucleus? A membership organisation Funded by sponsorship, membership fees, events and projects Based in Cambridge and London but with global members Formed by merger of ERBI and LBN Vision For One Nucleus and our members to be the top European life science and healthcare network With more than 470 members Biotech, pharma, medical device, diagnostics Technical and commercial service providers 30% Gold, 70% Silver Mission To maximise the global competitiveness of our members Focused 100% on delivering value to members
3 Key Technology Strengths Global biotech centre of excellence Many key scientific discoveries made in Cambridge or London Drug and biological therapy development Global engineering centre of excellence Electronics and processors Wireless connectivity Software and data management Much of the world s medical technology developed in Cambridge-Royston corridor Biotech/medtech convergence Devices to deliver biotech innovation Drug delivery, diagnostics
4 Convergence of stakeholders Up to 60 % of clinical trials in Europe are carried out in the UK, the majority of those in London. London is home to 3 of the 5 comprehensive and 4 of the 6 specialist biomedical centres of the National Institute for Health Research; 17 of the MRC s units centres and institutes; and CRUK s London Research Institute. More biotechnology venture capital groups than the next 10 largest European cities.
5 Life Sciences Hub Linkages Papworth and Addenbrookes Norwich Research Park Colworth Research Park BioPark GSK Babraham Research Campus
6 Networking and Partnering Francis Crick Institute planned for M initiative J&J Innovation Centre 2013 Cambridge BioCluster London Mayor announces Med City 2013 Stevenage BioCatalyst & GSK London Bio and finance cluster BioPark Cluster, Welwyn Garden City Babraham Campus expansion 2013/14 AstraZeneca relocate UK presence 2013
7 What do our members do? One Nucleus Bio - Therapeutics Bio- services Pharma Med Tech Investors Not-for profit IP Services Legal Services BD Advisors Drug Developnent Consulting Financial Services Other Professional Services
8 Networking and Partnering Regular member meetings Cambridge Network Meetings London BioWednesdays Socials in both locations Cambridge Life Science Leadership Series 2012 (x 3) ON Helix Conference Genesis Conference
9 Genesis Conference 9 Dec 2014, London, UK with 650+ delegates for thought leadership debate, exhibition and partnering Programme Partner Scrip Intelligence Inward missions from France, Canada, Germany, Spain, Italy, and US planned
10 Training Courses based on identified skills gaps: Introduction to drug development Introduction to management Commercial awareness Presentation skills for scientists Project management Laboratory health and safety Health and safety for representatives and managers Directing safety (IOSH accredited) Rates for members and non-members Courses also in London and Manchester Courses are CPD accredited
11 Special Interest Groups Small groups to discuss key business issues Human resources Project management Corporate governance Business development IP IT Regulatory affairs/clinical development Corporate communications Operations (combining security, health and safety, Purchasing) Training
12 Purchasing Scheme Preferred Supply Agreements (tendered, exclusive) now includes BioNow members: Stationery & IT consumables Pipette maintenance & calibration Bulk gases, cylinder gases and dry Ice Laboratory consumables and chemicals Life science products Laboratory equipment maintenance Support Supply Agreements (not tendered or exclusive) Courier services, stationery, hotels, insurance, travel, cleaning 3 million annual savings Example 1 20,000 saving on top 40 moist used lab consumables The cost saving alone makes it worth joining Example 2 49,559 saving (42%) against Fisher Scientific list prices vs 2,000 annual membership cost Example 3 8,000 pa cost saving (12%) on equipment maintenance plus improved service levels and payment terms Example 4 1,371 rebate under office supplies contract Example 5 3,267 saving by switching annual dry ice spend
13 International Formal MOU relations with: MassBIO, MassMedic on East coast US BayBIO and BIOCOM on West coast US Practical support for members engaging with overseas clusters and companies EU projects CEBR elsi One-on-One
14 BIO 2013 Dinner
15 Current Developments Convergence - Technology and Business International relationships - tangible outcomes, managed, focus M11 Med Tech Forum - Key London-Cambridge link - Complements the UK MediLink Coverage - Quarterly events, wider One Nucleus engagement One Nucleus Life Science Hubs - access for life science execs when travelling
16 One network for biotech, pharma, medical device and diagnostic businesses One network for Cambridge and London There is only One Nucleus
The UK Life Sciences Industry and the Public Markets, 2016/17. World class science, world class investment opportunities
The UK Life Sciences Industry and the Public Markets, 2016/17 World class science, world class investment opportunities Life sciences investment opportunity Biotechnology and related life science and healthcare
More informationBioeconomy and Opportunities in the Bio-based Industry of Malaysia. Dr. Abdul Manaf Mohamad Radzi
Bioeconomy and Opportunities in the Bio-based Industry of Malaysia Dr. Abdul Manaf Mohamad Radzi Malaysia s Strategic Advantages in Bioeconomy Government with strong interest in the Bioeconomy sector Abundance
More informationSwiss Medtech - Europe Medtech Development Dr. Patrik Frei September 2014 Suzhou
Swiss Medtech - Europe Medtech Development Dr. Patrik Frei September 2014 Suzhou 1 Overview 1. Overview European Medtech Venture Valuation: Independent assessment and valuation of technology driven companies
More informationEuropean bioregions : strengths and partnership strategies. The bioxclusters example BioPartnering Latin America cluster forum september 2013
European bioregions : strengths and partnership strategies. The bioxclusters example BioPartnering Latin America cluster forum september 2013 Contents Who we are Our goals Our activities Wha we can offer
More informationThe role of patients in clinical research
Biopeople Newsletter April: The role of patients in clinical research Pitch your life sc...page 1 of 10 Biopeople Newsletter April 2018 The role of patients in clinical research What is the place of patients
More informationBIOHEALTH INDUSTRY. Start Your Career in Wisconsin s BIOTECH AND BIOPHARMA MEDICAL DEVICE AND DIAGNOSTICS HEALTH RESEARCH INSTITUTES BIO- MANUFACTURE
Start Your Career in Wisconsin s BIOHEALTH INDUSTRY BIOTECH AND BIOPHARMA MEDICAL DEVICE AND DIAGNOSTICS HEALTH RESEARCH INSTITUTES DIGITAL HEALTH BIO- MANUFACTURE Be Part of Wisconsin s BIOHEALTH INDUSTRY
More informationBIOHEALTH INDUSTRY. Start Your Career in Wisconsin s BIOTECH AND BIOPHARMA MEDICAL DEVICE AND DIAGNOSTICS HEALTH RESEARCH INSTITUTES BIO- MANUFACTURE
Start Your Career in Wisconsin s BIOHEALTH INDUSTRY BIOTECH AND BIOPHARMA MEDICAL DEVICE AND DIAGNOSTICS HEALTH RESEARCH INSTITUTES DIGITAL HEALTH BIO- MANUFACTURE Be Part of Wisconsin s BIOHEALTH INDUSTRY
More informationKPI Definition Comment Relates to Baseline Target
IMI2 Key performance indicators (KPIs) Reporting on measuring and outcomes on the ten following Key Performance Indicators will be provided yearly as part of the IMI2 JU Annual Activity Reports for year
More informationPharmaceutical and Biotechnology Construction Sector Report - UK Analysis
Pharmaceutical and Biotechnology Construction Sector Report - UK 2016-2020 Analysis Published: 16/09/2016 / Number of Pages: 98 / Price: 795.00 Introduction and Overview The 3rd edition of the report'pharmaceutical
More informationPromotion and Sponsoring Options 2018
05/14 2018 Make use of the well known and widely acknowledged Bio M network to promote your event, company and competencies! Bio M serves as the central hub and catalyst between academic research, pharmaceutical
More informationInnovations in Drug Pricing and Reimbursement:
ADVISORY REPORT AM PL E PA G ES S A S G ES A FirstWord Dossier Advisory report and Reimbursement Published Copyright 2016 Doctor s Guide Publishing Limited Part of the FirstWord Dossier family of reports
More informationEuropean Biotech & Pharma Innovation Development Dr. Patrik Frei May 2014 Shanghai
European Biotech & Pharma Innovation Development Dr. Patrik Frei May 2014 Shanghai 1 Overview 1. Overview European Biotechs / Clusters 2. Trends in the Biotech & Pharma Venture Valuation: Independent assessment
More informationSupported by: Flanders Welcome Team Life Sciences
Supported by: Flanders Welcome Team Life Sciences 5 essential key ingredients Smart financing Innovation ecosystem Expertise to build and connect Talent Strategic location with a global reach Flanders
More informationThe East of England: growing the future
The East of England: growing the future of life sciences es in the UK The eastern region: where science and wellbeing grow together Look east for life science entrepreneurship and innovation Steeped in
More informationSMEs learn more about how to commercialise health related products at Lifescience Launchpad
Innovation Nexus Case Study 3 SMEs learn more about how to commercialise health related products at Lifescience Launchpad With such a diverse cohort of companies spanning drug development, diagnostics
More informationAustralia: A Dynamic Environment for Conducting Clinical Trials
Australia: A Dynamic Environment for Conducting Clinical Trials MTPConnect s goal is to accelerate the growth of Australia s MTP sector Industry Associations Governments Universities Researchers Investors
More informationBiotechnology Report CROATIA
Biotechnology Report CROATIA PREPARED BY AND IN 2009 Bulgaria Croatia Industry Report STATUS OF THE CROATIAN BIOTECHNOLOGY SECTOR (Financial data in ) 2 Total Biotech Companies 2 Biotech-Therapeutic 0
More informationWelcome to 5 th Munich Biomarker Conference
Clinical Practice and Targeted Therapies in Personalized Medicine Welcome to 5 th Munich Biomarker Conference December 1 st 2 nd, 2015 RAMADA Hotel & Conference Center München Messe We thank our sponsors
More informationGreater Manchester Health and Social Care Strategic Partnership Board
Greater Manchester Health and Social Care Strategic Partnership Board 9 Date: 13 October 2017 Subject: Report of: Health Innovation Manchester Update on Progress Rowena Burns, Executive Chair, Health Innovation
More informationCancer Research UK submission to House of Lords Science and Technology Committee inquiry on Scientific Infrastructure. June 2013
Cancer Research UK submission to House of Lords Science and Technology Committee inquiry on Scientific Infrastructure June 2013 1. Every year around 300,000 people are diagnosed with cancer in the UK.
More informationValuation and HealthTech in Asia Dr. Patrik Frei January 2017 San Francisco
Valuation and HealthTech in Asia Dr. Patrik Frei January 2017 San Francisco Overview Introduction to Valuation Valuation of a Company / Therapeutic Product Valuation in Asia / HealthTech Asia's healthcare
More informationSPONSORSHIP OPPORTUNITIES
CONFERENCES SPONSORSHIP OPPORTUNITIES 18 th International Conference on Medicinal and Pharmaceutical Chemistry October 18-19, 2018, 2018 Dubai, UAE our DELEGATE is your CLIENT Our Programme 5+ Keynote
More informationInaugural Fraunhofer Delaware Technology Summit
Inaugural Fraunhofer Delaware Technology Summit Energy and Life Sciences Solu
More informationto protect human health throughout the life-cycle of medicinal products;
ICMRA Communications Strategy: 2018-2020 Introduction The International Coalition of Medicines Regulatory Authorities (ICMRA) is a voluntary, highlevel, strategic coordinating, advocacy and leadership
More informationDRAFT DOCUMENT FINAL COPY TO REFLECT CONFIRMED. Embed Innovations to Transform Your R&D Procurement Model and. Drive Scientific Activities Efficiency
Embed Innovations to Transform Your R&D Procurement Model and Drive Scientific Activities Efficiency April 30 May 1, 2018 Boston, US This conference exceeded all of my expectations. The topics, speakers
More informationSAMPLE. North America Trauma Fixation Procedures Outlook to 2020
North America Trauma Fixation Procedures Outlook to 2020 Reference Code: GDMECR0008PDB Publication Date: March 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 3 1.2 List
More informationIdentifying Critical Factors Pre-launch
Identifying Critical Factors Pre-launch Incorporate pricing and market access into product planning Eric M. Bachman, Director Boston office One Canal Park Cambridge, MA 02141, USA Tel. +1 617 231 4592
More informationAdaption of healthcare systems in their management of innovation /hospital specialty products
Adaption of healthcare systems in their management of innovation /hospital specialty products Lisa Taylor Global Pricing and Market Access Principal, IMS Consulting Group Pressures in healthcare expenditures
More informationImproving Pa-ent Outcomes with Research: The Appliance of Science NIHR UCL Hospitals Biomedical Research Centre
Improving Pa-ent Outcomes with Research: The Appliance of Science NIHR UCL Hospitals Biomedical Research Centre Bryan Williams MD FRCP FESC FAHA Professor of Medicine and BRC Director 29/08/2013 Creating
More informationCLINICAL TRIAL STRATEGY AND REGULATORY APPROVAL. SIMS Biotech Executive Programme Module IV Barcelona, July 3-5, 2008
CLINICAL TRIAL STRATEGY AND REGULATORY APPROVAL SIMS Biotech Executive Programme Module IV Barcelona, July 3-5, 2008 Presentation Science and Innovation Management Studies (SIMS) is promoted by Biocat
More informationFIVE YEARS OF Innovation with Impact. Stevenage Bioscience Catalyst Five Year Review
FIVE YEARS OF Innovation with Impact Stevenage Bioscience Catalyst Five Year Review 2012-2017 Five years of Innovation with Impact SBC 2017 Facts and Figures 46 Current Tenants Continually focused on delivering
More informationResearch and development case study. Human health research
Research and development case study Human health research November 2017 Introduction This case study on human health research is one of a series that we have developed to support and complement our published
More informationLondon & Partners Strategy
London & Partners Strategy 2018-2021 Contents 1. Mission and remit p. 3 2. Executive Summary p. 4 3. Context p. 7 4. Strategic priorities p. 14 5. Key Performance Indicators p. 34 2 Mission and remit We
More informationTechnology Transfer, Academic and Industry Cooperations
Technology Transfer, Academic and Industry Cooperations Jake Micallef PhD MBA COO ValiRx plc Visiting lecturer Simfonec Jake.micallef@valirx.com What do they want? Universities Money to fund research and
More informationBrazil Capsule Endoscopy Procedures Outlook to 2020
Brazil Capsule Endoscopy Procedures Outlook to 2020 Reference Code: GDMECC0469PDB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 3 1.2 List of Figures...
More informationEUROPEAN TECHNOLOGY PLATFORM NANOMEDICINE. Work plan for GA, 16th January 2008
Work plan for 2008 1 Vision In 10 years nanomedicinebased products will lead to breakthroughs in the treatment of diseases such as cardiovascular disease, cancer, CNS diseases and diabetes. 2 The ETP is
More informationDevelop YOUR business in Medicon Valley Dedicated to helping you develop your business, Medicon Valley offers:
MEDICON VALLEY / 2011 03 Develop YOUR business in Medicon Valley Dedicated to helping you develop your business, Medicon Valley offers: > A pool of highly qualified life-science university graduates and
More informationFirst Steps in Procurement. Finance Training
First Steps in Procurement Finance Training First Steps in Procurement A course developed by Finance Training and Procurement specifically for the University. It is not accredited but is an excellent starting
More informationThe European Medicines Agency: A well-established Agency of the EU protecting human and animal health for all EU citizens
14 July 2016 EMA/457243/2016 The European Medicines Agency: A well-established Agency of the EU protecting human and animal health for all EU citizens 1. Who we are The European Medicines Agency (EMA)
More informationBGMA Associate Membership
BGMA Associate Membership Making medicines affordable Promoting Innovation November 2011 GENERICS -THE FACTS Generic medicines meet the same standards of quality, safety and efficacy as originator brands.
More informationInvestigating Clinical Trial Costs Comparative Analysis of Trial Cost Components in Key Geographies Table of Contents
Investigating Clinical Trial Costs Comparative Analysis of Trial Cost Components in Key Geographies Table of Contents Executive summary 14 Introduction and background to clinical trials 14 Financial considerations
More informationBrazil Gastric Balloon Procedures Outlook to 2020
Brazil Gastric Balloon Procedures Outlook to 2020 Reference Code: GDMECC0472PDB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 3 1.2 List of Figures...
More informationTHE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 118 PATIENT GROUPS with an interest in RESPIRATORY CONDTIONS
THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 118 PATIENT GROUPS with an interest in RESPIRATORY CONDTIONS PUBLISHED OCTOBER 2016 [Question to respondents: Which companies have the best record
More informationOn Helix. 02 July Harren Jhoti President & CEO
On Helix 02 July 2014 Harren Jhoti President & CEO Astex Pharmaceuticals Global developer of small molecule drugs for unmet medical needs Expertise in oncology discovery & development World-class fragment-based
More informationDoctor/pharma relationships: the latest research
Creating connections, improving healthcare Doctor/pharma relationships: the latest research medicine media metamorphosis The huge shift in knowledge sharing has affected how doctors interact with the healthcare
More informationSAMPLE. Mexico Orthopedic Prosthetics Market Outlook to Reference Code: GDMECC0156DB. Publication Date: February 2014
Mexico Orthopedic Prosthetics Market Outlook to 2020 Reference Code: GDMECC0156DB Publication Date: February 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 3 1.2 List of
More informationCEO BROOKER. Well-established listed Biotech.
BROOKER C o n s u l t i n g CEO Well-established listed Biotech Anatara Lifesciences is an ASX listed company located in Melbourne. With the execution of a major licensing deal with Zoetis, Anatara is
More informationFrance Spinal Surgery Procedures Outlook to 2020
France Spinal Surgery Procedures Outlook to 2020 Reference Code: GDMECC0027PDB Publication Date: March 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 3 1.2 List of Figures...
More informationStrategic vision of Pharma Market
Strategic vision of Pharma Market Evolution 2012-2016 ACIP Presentation, Paris January 30, 2013 Introduction This presentation draws strategic orientations for pharma companies considering the expected
More informationE&T objectives in evolving pharma business models. Magda Chlebus Director Science Policy Brussels, 2 March 2015
E&T objectives in evolving pharma business models Magda Chlebus Director Science Policy Brussels, 2 March 2015 Education adapted to demand? Declining number of students choosing science Education still
More informationHertfordshire Open for business. Hertfordshire. Local Enterprise Partnership
The Board Chair s Introduction Chair: John Gourd, Johnson Matthey is the fifth largest economy outside London. It is home to over one million people and 47,000 businesses. Our economy is worth around 25bn
More informationUnited States Orthopedic Bone Cement and Casting Materials Market. Outlook to 2020
United States Orthopedic Bone Cement and Casting Materials Market Reference Code: GDMECC0008DB Publication Date: March 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2
More informationNanotechnology and Advanced Materials for more effective Healthcare
Nanotechnology and Advanced Materials for more effective Healthcare This challenge taps into the potential of nanotechnologies and advanced materials to enable more effective therapies and diagnostics
More informationPassenger Experience Management
Passenger Experience Management 10 tips for the successful development and execution of for passengers travelling by road, rail, air and water Steve King Head of Services Research SPA Future Thinking Introduction,
More informationUK businesses and the EU RTD Framework Programme, FP5 to FP7
UK businesses and the EU RTD Framework Programme, FP5 to FP7 A presentation based on research carried out under contract to BIS, winter 2009/2010 Paul Simmonds 29 th October 2010 The EU RTD Framework Programme
More informationSpain Knee Replacement Procedures Outlook to 2020
Spain Knee Replacement Procedures Outlook to 2020 Reference Code: GDMECC0052PDB Publication Date: March 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 3 1.2 List of Figures...
More informationJob Description for EIT Health Spain Communications Lead
Job Description for EIT Health Spain Communications Lead About EIT Health EIT Health is a network of best-in-class health innovators backed by the EU. We collaborate across borders to deliver new solutions
More informationCategory Manager: Compliance. Recruitment Pack. Category Manager: Compliance 1 of 16 January Recruitment Pack
Category Manager: Compliance Category Manager: Compliance 1 of 16 January 2018 Contents 1. Your Application... 3 2. Welcome from Dave Neilson, Chief Executive... 4 3. About Fusion21... 5 4. Job Description
More informationR F D. Results Framework Document for Department of Bio-Technology ( )
R F D Results Framework Document for Department of Bio-Technology Vision Section 1: Vision, Mission, Objectives and Functions The vision of the department is to create biotechnology tools and technologies
More informationCompany Name: Advertiser Name: Billing Address: City/State/Zip: Phone: Fax: Contact Name and Title.
CanBiotech Insertion Order Outsourcing, Partnering, Technology Marketplace and Portal www.canbiotech.com The CanBiotech Networks Biotech, Pharmaceuticals, Medical Devices/Diagnostics, AgBiotechnology,
More informationABPI 3 YEAR STRATEGIC PLAN
ABPI 3 YEAR STRATEGIC PLAN 2009 2010 2011 Introduction The ABPI s 3 year strategic plan lays out the Association s commitment to becoming world class: to surpass member s requirements; to lead the industry
More informationSUSTAINABLE DEVELOPMENT MANAGEMENT PLAN 2018/ /20
SUSTAINABLE DEVELOPMENT MANAGEMENT PLAN 2018/19 2019/20 Version number Summary of changes Ratified By/Date & date 0.1 Approval of draft plan BHR CCGs Joint Management Team - Date to be confirmed 1.0 Approval
More informationBioTech_InnoCluster-IVD Development, manufacturing and sales of in vitro diagnostic (IVD) medical devices, equipment, reagents and agents and services
BioTech_InnoCluster-IVD Development, manufacturing and sales of in vitro diagnostic (IVD) medical devices, equipment, reagents and agents and services Good practice: PROJECT Country: Hungary 27 January,
More informationELRIG EVENTS PROSPECTUS
ELRIG EVENTS PROSPECTUS 2018 www.twitter.com/@elrig_uk www.linkedin.com/company/elrig www.facebook.com/elriguk www.elrig.org ELRIG Events 2018 Welcome to ELRIG s 2018 events programme. After a hugely successful
More informationMaximising Malaysia s Role in the Global Biopharmaceutical Value Chain
Maximising Malaysia s Role in the Global Biopharmaceutical Value Chain Martyn Postle Cambridge Healthcare & Biotech EU-Malaysia Biotechnology Business Partnership 2007 Malaysia intends to become a global
More informationChallenges and Opportunities in Pharma: Perspective for an Emerging Middle East April 24th, 2015
Challenges and Opportunities in Pharma: Perspective for an Emerging Middle East 2020 April 24th, 2015 Content Pharma Market Landscape Global Pharma Market Market Categories Middle East Markets Major Challenges
More informationThe Innovate UK response to the Innovative Medicines Initiative consultation Facilitating the translation of advanced therapies to patients in Europe
The Innovate UK response to the Innovative Medicines Initiative consultation Facilitating the translation of advanced therapies to patients in Europe Innovate UK and ATMP background 1. Innovate UK is the
More informationThe Birmingham Institute of Translational Medicine. Professor Charles Craddock
The Birmingham Institute of Translational Medicine Professor Charles Craddock Challenges in delivering on a translational medicine agenda After decades of investment in basic research it is now apparent
More informationL A B O R M A R K E T B R I E F I N G S S E R I E S
L A B O R M A R K E T B R I E F I N G S S E R I E S LABOR MARKET INFORMATION FOR RESEARCHERS THE LIFE SCIENCE AND PHARMACEUTICALS SECTOR IN EUROPE L I F E S C I E N C E A N D P H A R M A C E U T I C A
More informationValuation of Biosimilar and Key Value Drivers Dr. Patrik Frei October 2015 Biosimilars Asia
Valuation of Biosimilar and Key Value Drivers Dr. Patrik Frei October 0 Biosimilars Asia Agenda Introduction Valuation of Biosimilar Key Value Driver / Conclusion Venture Valuation Independent assessment
More informationSave the Date April 3-4, 2014
Save the Date April 3-4, 2014 Management Issues in the Life Science Industry with Eric Le Royer, Fredrik Ragmark and many more interesting speakers Prepared and Supported by Smerud Medical Research International
More informationLife Sciences Financing Summary EU August 2017
EU August 2017 In May 2017, we saw a sharp increase in private investments in Biotech (Therapeutic and ) companies at EUR 181m, up over twofold from the previous month, with an average deal size of EUR
More informationINSTITUTE OF BIOMEDICAL SCIENCE
INSTITUTE OF BIOMEDICAL SCIENCE CORPORATE STRATEGY 2015-2018 Corporate Strategy 2015-2018 Page 1 of 8 Corporate Strategy 2015 2018 Vision, Mission and Values Our vision We aim to be the world s leading
More informationTranslational Research
Translational Research Paddy Johnston Chair, MRC Translational Research Overview Group October 2012 Translational Research Strategy and its delivery To accelerate patient benefit and increase economic
More informationPharma R&D and Patents support Health Care & Economy
Pharma R&D and Patents support Health Care & Economy Konstantinos Μ. Frouzis President of SFEE, V.P & Gen. Manager of Novartis Hellas April 28 th, 2014 Intellectual Property Patents: The vehicle for innovation
More informationJapan Negative Pressure Wound Therapy (NPWT) Market Outlook to 2020
Japan Negative Pressure Wound Therapy (NPWT) Market Outlook to 2020 Reference Code: GDMECC0963DB Publication Date: October 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables...
More informationEuropean Pharmaceutical Policy: Access for Patients or Improving Competitiveness
European Pharmaceutical Policy: Access for Patients or Improving Competitiveness The s Vision Dr Stefaan Van der Spiegel Policy Officer, Unit F5 DG Enterprise and Industry Study day OSE / RIZIV-INAMI Brussels,
More informationLSE Health Market Access Academy April 2018, London September 2018, London
LSE Health Market Access Academy 9 13 April 2018, London 10 14 September 2018, London In cooperation with the Boston Consulting Group Market Access Roundtable LSE Health Market Access Academy 2 The London
More informationSouth Korea Ultrasound Systems Market Outlook to 2020
South Korea Ultrasound Systems Market Outlook to 2020 Reference Code: GDMECC0289DB Publication Date: March 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2 List of Figures...
More informationBayer s Contribution to a Healthier Society
Bayer s Contribution to a Healthier Society 12th Japan-Germany Industry Forum in Tokyo Dec. 1 st, 2016 / Hans-Dieter Hausner, President and Senior Bayer Representative at Bayer Holding Ltd. Our Mission
More information8 TH ANNUAL Global Fund Finance Symposium
8 TH ANNUAL Global Fund Finance Symposium MARCH 21, 2018 I GRAND HYATT - NEW YORK 2018 Sponsorship Opportunities PLATINUM PLATINUM LEVEL $20,000 Up to two (2) speaking opportunities on conference panels.
More informationEuropean Induced Pluripotent Stem Cell Bank
European Induced Pluripotent Stem Cell Bank Background Researchers are looking for ways to validate pathways using human data. ips cells are one approach to this. ips research and banking is fragmented
More informationbasic business essentials of biotechnology
basic business essentials of biotechnology SIMS Executive course Module 1 June 29 - July 1, 2006 Co-directed with: Introduction Science and Innovation Management Studies (SIMS), is organized by the Barcelona
More informationEvent Prospectus SAS Europe Recharge
Event Prospectus SAS Europe Recharge 23-24 January, 2018 Zoku Amsterdam, The Netherlands ABOUT THE EVENT A NOTE FROM THE EDITOR From its humble beginnings as a 13th-century fishing village on a river bed
More informationSAMPLE. South Korea MRI Systems Market Outlook to Reference Code: GDMECC0287DB. Publication Date: March 2014
South Korea MRI Systems Market Outlook to 2020 Reference Code: GDMECC0287DB Publication Date: March 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 3 1.2 List of Figures...
More information<Insert Picture Here> Healthcare and Life Sciences Mission & Strategy. Leo Liang Vice President HSGBU Japan and APAC
Healthcare and Life Sciences Mission & Strategy Leo Liang Vice President HSGBU Japan and APAC The following is intended to outline our general product direction. It is intended for
More informationConvergence and difference in HTA approaches in UK, Germany and France: reflections on recent and proposed changes
Convergence and difference in HTA approaches in UK, Germany and France: reflections on recent and proposed changes Professor Ron Akehurst School of Health and Related Research Content of Talk During this
More informationengaging with the strata community
engaging with the strata community Sponsorship Prospectus WA Financial Year 17/18 Released May 2017 engaging in the business of strata 2 Strata Community Australia is the peak industry body representing
More informationA comparative analysis of seven world leading biotech clusters
June 2017 A comparative analysis of seven world leading biotech clusters English summary 1 Content 1. Background and approach... 2 1.1. Background... 2 1.2. Methodological approach... 2 1.3. Contributors...
More informationCLICK & BUY TRAINING GUIDE: TRANSACTING WITH COTY FOR INDIRECT VENDORS
CLICK & BUY TRAINING GUIDE: TRANSACTING WITH COTY FOR INDIRECT VENDORS OVERVIEW Coty has chosen the Ariba platform for the management of our indirect spend. This document is designed to help you, our business
More informationGOVERNANCE STRATEGY October 2013
GOVERNANCE STRATEGY October 2013 1. Introduction 1.1. The Central Manchester University Hospitals NHS Foundation Trust believes that the role of the governing body is pivotal to the success of the Trust.
More informationUniversity of Northampton Enterprise Priorities
University of Northampton Enterprise Priorities 2017-2020 1 University of Northampton Enterprise Priorities 2017 2020 Aim The aim of the University of Northampton s Enterprise and enterprise plan for 2017
More informationPromoting the Biotechnology Industry in Germany
Positions Promoting the Biotechnology Industry in Germany Germany s biotechnology industry ranks among the most sustainable and forward looking of today s cutting-edge technologies. Biotechnology is about
More informationTAIWAN. Who Should Attend? Endless Potential & Opportunities. Where innovations are shaping a new era of intelligent healthcare.
TAIWAN Where innovations are shaping a new era of intelligent healthcare World-class medical centers and hospitals Over 1800 biotech companies Best healthcare system in the world Top-ranked life science
More informationQuality Improvement Strategy Improvement through empowerment and innovation
Quality Improvement Strategy Improvement through empowerment and innovation 2018 2022 VR.1.1 Corporate Strategy The Quality Improvement Strategy supports the delivery of the Trust s corporate strategy.
More informationPharmaceutical and Biotechnology Construction Sector Report - UK
Pharmaceutical and Biotechnology Construction Sector Report - UK 2018-2022 Published: 26/09/2018 / Number of Pages: 99 / Price: 895.00 Introduction and Overview The 4th edition of the 'Pharmaceutical &
More informationGUIDE HEA
Companies are often overwhelmed by the field of digital health. From digital and med device companies to biotechnology and pharmaceutical companies, there is a struggle to cut through the noise of numerous
More informationBiotechnology Report. Latvia
Biotechnology Report Latvia PREPARED BY AND IN 2009 Cyprus Bulgaria Croatia Czech Estonia Hungary Latvia Industry Republic Report STATUS OF THE LATVIAN BIOTECHNOLOGY SECTOR (Financial data in ) 6 Total
More informationCAREER DEVELOPMENT FOR EXPERIENCED REGULATORY PROFESSIONALS
CAREER DEVELOPMENT FOR EXPERIENCED REGULATORY PROFESSIONALS How TOPRA can support you as you drive your regulatory career forward ABOUT TOPRA TOPRA (The Organisation for Professionals in Regulatory Affairs)
More informationPREVIEW. Benchmarking European Investigator Payments Industry Standard Research
PREVIEW Benchmarking European Investigator Payments Info@ISRreports.com 2014 Industry Standard Research www.isrreports.com Report Overview This report provides an analysis of Europe s clinical trial compensation
More information